Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19

The rapid spread of SARS-CoV-2 infection globally coupled with the relatively high case-fatality rate has led to immediate need for therapeutic intervention to prevent and treat COVID-19 disease. There is accumulating evidence that morbidity and mortality in COVID-19 may be exacerbated by a dysregul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Tamara, Wahezi, Dawn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387280/
https://www.ncbi.nlm.nih.gov/pubmed/32792288
http://dx.doi.org/10.1016/j.prrv.2020.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387280/
https://www.ncbi.nlm.nih.gov/pubmed/32792288
http://dx.doi.org/10.1016/j.prrv.2020.07.003

Ejemplares similares